Welcome to the Week in Review.

1.  Patients Urge Senators To Curb Patent Abuses📝

 2.  Defending Medicare Negotiation 

3. The Inflation Reduction Act: A Clear Win For Patients 

One more thing: A new contract between drug company Regeneron and HHS marks “the first time the Biden administration has directly used its leverage to challenge drugmakers’ list prices.” Rachel Cohrs at STAT has the breakdown.

Have a great weekend!